APCER PHARMA to demonstrate pharmacovigilance/drug safety and regulatory services at GPhA meeting

APCER PHARMA (“APCER”) executives will discuss and demonstrate their expertise in providing generic drug manufacturers with the best in class pharmacovigilance/drug safety, regulatory and risk management services at the GPhA Annual Meeting, February 16-18, at the Ritz-Carlton in Naples, Florida. APCER will be in Booth #27.

“APCER is repeatedly chosen as the safety and regulatory services provider by pharmaceutical companies because our team knows what it takes to provide a compliant, best in class solution, at a very effective price.”

APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.

APCER President and CEO Suneet Walia explained, “APCER is repeatedly chosen as the safety and regulatory services provider by pharmaceutical companies because our team knows what it takes to provide a compliant, best in class solution, at a very effective price.”

APCER uses leading systems on a secure, hosted platform to handle customers’ requirements at virtually a fraction of the cost of what it would normally cost a company to implement their own system. The team at APCER is experienced and the operations truly global. APCER currently does case reporting on behalf of its clients in 68 countries and has a team on the ground in North America, Europe and Asia that works closely with its customers to provide round the clock service.